Tuinal: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== Tuinal == | |||
[[File:Secobarbital_and_amobarbital.svg|thumb|Chemical structure of Secobarbital and Amobarbital]] | |||
[[File:Tuinal_DOJ.jpg|thumb|Tuinal capsules]] | |||
'''Tuinal''' is a combination [[barbiturate]] [[medication]] that contains equal parts of two barbiturate salts: [[secobarbital]] and [[amobarbital]]. It was introduced in the late 1940s by [[Eli Lilly and Company]] as a sedative and [[hypnotic]] for the treatment of [[insomnia]] and other sleep disorders. | |||
Tuinal was | |||
== | == History == | ||
Tuinal was first introduced in 1946 and became widely used in the 1950s and 1960s. It was marketed as a prescription medication for patients who required a strong sedative. However, due to its potential for abuse and addiction, its use declined over the years. | |||
== Pharmacology == | |||
Tuinal acts as a central nervous system [[depressant]]. The combination of secobarbital and amobarbital enhances the inhibitory neurotransmitter [[gamma-aminobutyric acid]] (GABA) in the brain, leading to sedative and hypnotic effects. The drug has a rapid onset of action and a relatively short duration of effect. | |||
== Medical Uses == | |||
Tuinal was primarily prescribed for the short-term treatment of severe insomnia. It was also used as a pre-anesthetic agent and for the treatment of certain types of seizures. Due to its high potential for dependence and overdose, it is no longer commonly prescribed. | |||
== | == Abuse and Dependence == | ||
Tuinal | Tuinal has a high potential for abuse and can lead to physical and psychological dependence. Overdose can result in severe respiratory depression, coma, and death. As a result, its use is now highly restricted. | ||
== Legal Status == | == Legal Status == | ||
Due to its potential for abuse, Tuinal is classified as a [[Schedule II controlled substance]] in the United States. This classification indicates that it has a high potential for abuse, with use potentially leading to severe psychological or physical dependence. | |||
== | == Related Pages == | ||
* [[Barbiturate]] | * [[Barbiturate]] | ||
* [[Secobarbital]] | * [[Secobarbital]] | ||
* [[Amobarbital]] | * [[Amobarbital]] | ||
* [[Insomnia]] | * [[Insomnia]] | ||
* [[ | * [[Central nervous system depressant]] | ||
== References == | |||
{{Reflist}} | |||
[[Category:Barbiturates]] | [[Category:Barbiturates]] | ||
[[Category:Sedatives]] | [[Category:Sedatives]] | ||
[[Category:Hypnotics]] | [[Category:Hypnotics]] | ||
<gallery> | |||
File:Secobarbital_and_amobarbital.svg|Chemical structure of Secobarbital and Amobarbital | |||
File:Tuinal_DOJ.jpg|Tuinal capsules | |||
</gallery> | |||
Latest revision as of 01:59, 17 February 2025
Tuinal[edit]


Tuinal is a combination barbiturate medication that contains equal parts of two barbiturate salts: secobarbital and amobarbital. It was introduced in the late 1940s by Eli Lilly and Company as a sedative and hypnotic for the treatment of insomnia and other sleep disorders.
History[edit]
Tuinal was first introduced in 1946 and became widely used in the 1950s and 1960s. It was marketed as a prescription medication for patients who required a strong sedative. However, due to its potential for abuse and addiction, its use declined over the years.
Pharmacology[edit]
Tuinal acts as a central nervous system depressant. The combination of secobarbital and amobarbital enhances the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to sedative and hypnotic effects. The drug has a rapid onset of action and a relatively short duration of effect.
Medical Uses[edit]
Tuinal was primarily prescribed for the short-term treatment of severe insomnia. It was also used as a pre-anesthetic agent and for the treatment of certain types of seizures. Due to its high potential for dependence and overdose, it is no longer commonly prescribed.
Abuse and Dependence[edit]
Tuinal has a high potential for abuse and can lead to physical and psychological dependence. Overdose can result in severe respiratory depression, coma, and death. As a result, its use is now highly restricted.
Legal Status[edit]
Due to its potential for abuse, Tuinal is classified as a Schedule II controlled substance in the United States. This classification indicates that it has a high potential for abuse, with use potentially leading to severe psychological or physical dependence.
Related Pages[edit]
References[edit]
<references group="" responsive="1"></references>
-
Chemical structure of Secobarbital and Amobarbital
-
Tuinal capsules